Some bisphosphonates may halve CRC risk: study 10 Aug 2011 0 comments Patients taking bisophosphonates may reduce their cancer risk by taking particualar drugs in the class, suggests preliminary research.
Anti-TNF for Crohn’s on PBS 30 Mar 2011 0 comments The anti-TNF adalimumab (Humira) will be available on the Pharmaceutical Benefits Scheme from this Friday for the treatment of adults with complex refractory fistulising Crohn′s disease.